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It  is  now  generally  agreed  that  there  are  inherent  sex differences  in  healthy  individuals  across  a  number  of
neurobiological  domains  (including  brain  structure,  neurochemistry,  and  cognition).  Moreover,  there  is a
burgeoning  body  of  evidence  highlighting  sex  differences  within  neuropsychiatric  populations  (in  terms
of the  rates  of  incidence,  clinical  features/progression,  neurobiology  and pathology).  Here,  we consider
the extent  to  which  attention  and  impulsivity  are  sexually  dimorphic  in healthy  populations  and  the
extent  to  which  sex  might  modulate  the  expression  of  disorders  characterised  by  abnormalities  in atten-
tion  and/or  impulsivity  such  as  attention  deﬁcit  hyperactivity  disorder  (ADHD),  autism  and  addiction.
We  then  discuss  general  genetic  mechanisms  that  might  underlie  sex  differences  in  attention  and  impul-
sivity  before  focussing  on speciﬁc  positional  and  functional  candidate  sex-linked  genes that  are  likely
to  inﬂuence  these  cognitive  processes.  Identifying  novel  sex-modulated  molecular  targets  should  ulti-
mately enable  us  to develop  more  effective  therapies  in disorders  associated  with attentional/impulsiveutism
RY
AOA
teroid sulfatase
eurosteroids
urner syndrome
OMT
dysfunction.
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. Introduction
Ever more sophisticated neuroscientiﬁc approaches have
trengthened the notion of a considerable degree of neural sex-
al dimorphism amongst healthy individuals (Cahill, 2006; Jazin
nd Cahill, 2010). Sex differences in structure/function have been
bserved for a number of brain regions underlying higher cognitive
nd ‘emotional’ processes including the hippocampus (Goldstein
t al., 2001; Madeira and Lieberman, 1995), the amygdala (Hamann,
005; Mechelli et al., 2005) and the prefrontal cortex (PFC)
Goldman et al., 1974; Shansky et al., 2004). Moreover, the sexes
eem to differ signiﬁcantly with respect to their neurochemical sys-
ems (Craft, 2003; Galanopoulou, 2005), notably the monoamine
ystem (Nishizawa et al., 1997; Robinson et al., 1977).
There is perhaps even more compelling evidence for sexual
imorphic features in many neuropsychiatric disorders, notably
n terms of their incidence, their clinical features and progression,
nd in their underlying pathology (Holden, 2005; Klein and Corwin,
002). A large proportion of neuropsychiatric disorders, including
ttention deﬁcit hyperactivity disorder (ADHD), autism, pathologi-
al gambling, depression and schizophrenia, are characterised by
mpairments in higher cognitive functions; two domains which
re consistently reported as being abnormal in such disorders are
ttention and impulsivity (American Psychiatric Association, 1994;
laszczynski et al., 1997; Chen and Faraone, 2000; Moritz et al.,
002; Simonoff et al., 2008). Moreover, there is substantial evidence
o suggest that attention/impulsivity may  be inﬂuenced by com-
on  brain substrates such as regions of prefrontal cortex (Bush,
010; Cardinal, 2006; Coull et al., 1996). Here, we examine the
vidence for these two neuropsychological domains being sexu-
lly dimorphic in both healthy individuals and individuals with a
sychiatric diagnosis using PubMed searches (keywords included
sex’ or ‘gender differences’, ‘attention’ or ‘attentional’, ‘impulsive’
r ‘impulsivity’, ‘ADHD’, ‘stop signal’, ‘delay discounting’ or ‘aver-
ion’, ‘response inhibition’ and others). Furthermore, we  suggest
enetic mechanisms that may  mediate any sex bias and three can-
idate sex-linked genes are considered. Much of our discussion will
ocus on ADHD, the archetypal disorder of attention and impulsiv-
ty (American Psychiatric Association, 1994). It is estimated that
reater than 75% of ADHD diagnoses are made in males (Pastor and
euben, 2008; Schneider and Eisenberg, 2006), and whilst this ﬁg-
re may  be partly confounded by ascertainment and referral biases
Biederman et al., 2002; Derks et al., 2007), it is also likely to reﬂect
ome sex-speciﬁc difference in biological vulnerability (Waddell
nd McCarthy, 2011).
. A brief introduction to attention and impulsivity
All animals live in a world of competing, multiple and simulta-
eous stimuli that must be resolved in order so that they behave
daptively. Attention represents the ability to select from a plethora
f stimuli, responses, memories and thoughts, and in doing so, dis-
egard any that are behaviourally irrelevant (Raz, 2004); ‘attention’
ay be regarded as a unitary description of three neurobiologically
isparate attentional control systems: ‘alerting’, ‘orienting’ and
executive’ (Posner and Petersen, 1990; Raz and Buhle, 2006). ‘Alert-
ng’ relates to preparedness for an impending stimulus by achieving
nd maintaining an alert state (it may  also be termed as ‘sustained
ttention’ or ‘vigilance’). Parallel neuroimaging and neuropsycho-
ogical studies have revealed that the alert state corresponds to
ctivity in the prefrontal and parietal cortices, particularly in the
ight hemisphere (Coull et al., 1996), and is dependent upon the
oradrenaline system (Beane and Marrocco, 2004; Marrocco et al.,
994). Orienting (also known as ‘scanning’ or ‘selection’) refers to
he ability to select information from multiple sensory stimuli, and
as been reported to be associated with superior parietal cortexychology 89 (2012) 1– 13
activity (Corbetta et al., 2000), and superior colliculus activity (overt
attentional shifts; Corbetta, 1998). The disengagement of attention
when a target occurs at an uncued location is thought to involve the
temporo-parietal junction and superior temporal lobe (Friedrich
et al., 1998; Karnath et al., 2001). The cholinergic system is thought
to play an important role in orienting through its effects on the pari-
etal cortex (Beane and Marrocco, 2004; Parasuraman et al., 1992;
Tales et al., 2002; Voytko et al., 1994) and cholinergic agonists
have been shown to reduce neural activity and reaction times on
invalidly cued trials (Thiel et al., 2005). ‘Executive attention’ (also
referred to as ‘supervisory’, ‘selective’ and ‘focussed attention’) is
the complex monitoring and resolution of conﬂict between diverse
brain regions and is classically measured through tasks such as
the Stroop task (Stroop, 1935) which possess an incompatibility
between the dimensions of the stimulus that must be resolved. In
the Stroop test, the incongruent condition of the word red printed
in blue ink must be resolved such that subjects correctly report the
colour of the ink and inhibit the prepotent process of stating the
printed word. Neuroimaging studies have identiﬁed the anterior
cingulate cortex (ACC) as a key brain region in executive attention
given that the dorsal ACC is consistently activated in ‘conﬂict’ tasks
(Fan et al., 2003a).  It is currently unclear whether the ACC monitors
conﬂict by engaging the dorsolateral prefrontal cortex (Botvinick
et al., 2004), whether it resolves conﬂict (at response, not stimulus
level) (Liu et al., 2004; Milham et al., 2001) or whether it does both
(Bush et al., 2000). The ACC and dorsolateral prefrontal cortex are
both targets of the mesocortical dopamine pathway (Marrocco and
Davidson, 1998), so it has been postulated that the executive atten-
tional network is especially sensitive to dopaminergic function and
pharmacological manipulation (Raz, 2004; Raz and Buhle, 2006).
As with attention, a single deﬁnition that encapsulates all
aspects of impulsivity has so far proved elusive (Winstanley et al.,
2006) and this likely derives from its considerable heterogeneity
(Evenden, 1999b). Broadly, impulsivity describes several phenom-
ena pertaining to ‘action without forethought’ that forms part of
everyday behaviour and, in some instances, contributes to adverse
states such as drug addiction (Moeller et al., 2001), gambling (Steel
and Blaszczynski, 1998) and ADHD (Sagvolden et al., 1998). Impul-
sivity may  be sub-classiﬁed into at least two  distinct theoretical
entities: ‘impulsive action’ (associated with a lack of behavioural
inhibition) and ‘impulsive choice’ (decision-making without appro-
priate deliberation of the alternative options) (Evenden, 1999a).
Impulsive action includes premature/mistimed actions and actions
that are difﬁcult to control/suppress and are commonly measured
experimentally in humans and rodents using Go/No-go and Stop-
signal Reaction Time (SSRT) tasks (Band and van Boxtel, 1999; Eagle
and Robbins, 2003; Harrison et al., 1999). Impulsive choice is exem-
pliﬁed by aversion to delayed reward (Dalley et al., 2008) and is
often measured experimentally using delay-discounting paradigms
whereby impulsivity is observed as a greater tendency towards a
small, immediate reward over a larger, delayed reward (Cardinal
et al., 2004). However, the theoretical classiﬁcation of impulsivity
often overlooks the complicated and myriad forms of manifesta-
tion at the phenotypic level, such as the concomitant expression of
impulsivity and aggression, known as impulsive aggression, which
is commonly observed in antisocial personality and borderline per-
sonality disorders (Seo et al., 2008).
Numerous studies investigating the neuroanatomical circuitry
of impulsivity have demonstrated the key role that the frontal
cortex plays in humans (Brass and von Cramon, 2002; Cardinal,
2006; Dove et al., 2000; Mecklinger et al., 1999). This is particu-
larly evident in human subjects with damage to the right inferior
frontal gyrus and ventromedial frontal cortex, who subsequently
display deﬁcits in stop-signal inhibition (Aron et al., 2003) and poor
decision-making in a gambling task (Bechara et al., 1994), respec-
tively. Systematic lesion studies in rats have begun to dissociate
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etween regions of the brain underlying different aspects of impul-
ivity (reviewed in Winstanley et al., 2006). To date, these implicate
he infralimbic, anterior cingulate and orbitofrontal regions of the
rontal cortex (but not the prelimbic) and the medial striatum
s mediators of impulsive action as measured by the 5-choice
erial reaction time task (5-CSRTT), where rats must refrain from
esponding to a stimulus prematurely. These lesion studies have
rovided convincing evidence that the neurobiology underlying
mpulsive action and impulsive choice may  be dissociable to some
xtent (Winstanley et al., 2006), in that whilst lesions of the nucleus
ccumbens increase both subtypes of impulsivity (Cardinal et al.,
001; Christakou et al., 2004), lesions to either the orbitofrontal cor-
ex or subthalamic nucleus increase impulsive actions, but result in
n increased tolerance to delay (Winstanley et al., 2004, 2005).
Research into the underlying neurochemistry of impulsivity
as focussed on dopaminergic, serotonergic, noradrenergic and
lutamatergic pathways (Cardinal et al., 2004; Eagle and Baunez,
010; Pattij and Vanderschuren, 2008). The dopaminergic system
as been implicated in impulsivity phenotypes by the observation
hat psychostimulant drugs which enhance dopamine release from
opaminergic terminals and/or prevent dopamine reuptake (e.g.
ethylphenidate and d-amphetamine) can be used to treat dis-
rders of impulsivity such as ADHD (Sandoval et al., 2002; Tripp
nd Wickens, 2009; Volkow et al., 1998). d-Amphetamine enhances
top-signal task performance in both humans and rats (de Wit  et al.,
000; Feola et al., 2000), although it has been shown to increase
remature responding in the 5-CSRTT and other similar tasks (Cole
nd Robbins, 1987; Pattij and Vanderschuren, 2008; van Gaalen
t al., 2009; Wiskerke et al., 2011). Meanwhile, d-amphetamine
as been shown to decrease impulsive choice in delay-discounting
asks (de Wit  et al., 2002; Isles et al., 2003), but conversely, an
ncrease in impulsive choice has also been demonstrated (Wiskerke
t al., 2011). There is generally considered to be an inverse cor-
elation between 5-HT levels and impulsive action (Crean et al.,
002; Harrison et al., 1997; Walderhaug et al., 2002), although it
s unclear if the same is true of delay-aversion (Cardinal, 2006).
he involvement of noradrenergic and glutamatergic pathways in
mpulsivity has been suggested by the ability of noradrenaline
euptake inhibitors (e.g. atomoxetine) to reduce impulsive action
cross species (Chamberlain et al., 2006; Robinson et al., 2008) and
MDA antagonists/metabotropic glutamate receptor antagonists
o modulate impulsive action (Higgins et al., 2003; Sukhotina et al.,
008), respectively.
. Sex differences in attention and impulsivity in healthy
ndividuals
A priori, one might anticipate sex differences in attention and
mpulsivity, given that brain regions underpinning these functions
described above) differ considerably between the sexes in terms
f their development and ongoing function (Bland et al., 2005; Duff
nd Hampson, 2001; Goldman et al., 1974; Shansky et al., 2004).
he scientiﬁc literature documents a surprisingly small number
f objective neuropsychological studies assaying sex differences
n attention and impulsivity in healthy individuals. Several stud-
es have suggested a female advantage with respect to executive
ttention/response inhibition as indexed by Stroop task perfor-
ance (Moering et al., 2004; van Boxtel et al., 2001; Van der Elst
t al., 2006), possibly related to sex differences in corpus callosum
orphology throughout adolescence (Silveri et al., 2006); however,
ther studies have not recognised an equivalent behavioural effect
Klein et al., 1997; Swerdlow et al., 1995). In contrast, males may
utperform females on an oddball task tapping visuospatial selec-
ive attention, and may  activate different neural structures: during
his task, men  showed increased activation in the left hemisphericychology 89 (2012) 1– 13 3
inferior temporo-parietal region whilst women exhibited increased
activation of the right-hemispheric inferior frontal, insula, putamen
and superior temporal regions (Rubia et al., 2010).
With regard to impulsive action, behavioural performance on
the SSRT task does not seem to be modulated to any great extent
by sex; however, sex does seem to inﬂuence the function of sev-
eral brain regions associated with behavioural output including
the cingulate cortex, corpus callosum, the globus pallidus and the
thalamus, suggesting either diverse neural strategies or compen-
satory brain mechanisms which may  act to ensure sex-matched
performance (Huster et al., 2011; Li et al., 2006). No similar
studies have been conducted to assess sexual dimorphism in impul-
sive choice directly. However, impaired planning and therefore
decision-making are clearly implicit in impulsivity and studies
have shown sexual dimorphism in terms of the underlying neu-
ral substrates of decision-making (Bolla et al., 2004; Tranel et al.,
2005). Here, males have been shown to outperform women in
the extensively used Iowa Gambling Task (Overman, 2004; Reavis
and Overman, 2001). Using this task, right hemisphere PFC lesions
impaired decision-making in men, but not in women, whereas the
reverse was true of left hemisphere lesions (Tranel et al., 2005).
4. Sex differences in attention and impulsivity in
neuropsychiatric disorders
4.1. Attention deﬁcit hyperactivity disorder (ADHD)
ADHD is a common neurodevelopmental disorder (Polanczyk
et al., 2007) with a strong genetic basis (Wallis et al., 2008),
characterised by deﬁcits in attention, pathological impulsivity
and extreme hyperactivity. Individuals with ADHD are typically
diagnosed as having one of the three subtypes: the inattentive
subtype (showing inattentive symptoms in isolation and often
associated with an introspective, distractible, disorganised per-
sona), the hyperactive-impulsive subtype (showing hyperactivity
and impulsive symptoms, but few, if any, inattentive symptoms,
often associated with an energetic, extrovert, thrill-seeking, impa-
tient, and potentially aggressive persona) and combined subtype
(an amalgam of the previous two  subtypes) (American Psychiatric
Association, 1994). The phenotypic dissociation between the
inattentive subtype, and the remaining subtypes has led some
researchers to propose that they should be regarded as nosolog-
ically separate entities, underpinned by discrete neurobiologies,
and sensitive to distinct treatment regimes (Larsson et al., 2006;
Polanczyk et al., 2007; Solanto et al., 2009; Stein et al., 2003). The
sex discrepancy in overall ADHD prevalence is considerable (sub-
stantially increased prevalence in males) (Holden, 2005; Swanson
et al., 1998), and furthermore, appears to be subtype-speciﬁc: inat-
tentive ADHD is most prevalent amongst girls (Biederman et al.,
2002), whereas hyperactive-impulsive and combined subtypes are
thought to be more common in boys (Adler et al., 2008). Thus, sex
differences in presentation of the disorder may  feasibly account for
sex-speciﬁc differences in referrals and diagnosis (Biederman et al.,
2002; Lahey et al., 1994).
In terms of symptomatology, females diagnosed with ADHD
may  present with lower ratings of hyperactivity, inattention,
impulsivity and externalising problems (e.g. aggression) than
ADHD males, but greater intellectual impairments and more inter-
nalising problems (e.g. affective, eating and somatisation disorders)
(Gershon, 2002). In contrast, abuse and criminality appear to be
more prevalent amongst ADHD males (Gershon, 2002). To date,
there has been little research explicitly examining whether male
and female ADHD patients differ in their performance on atten-
tion and impulsivity tasks. One study, employing both the Stroop
and the stop-signal tasks, found no signiﬁcant sex difference within
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he ADHD patient population (Rucklidge and Tannock, 2002). In
ontrast, a recent meta-analysis of stop-signal studies found a bor-
erline effect of gender, whereby behavioural inhibition in male
DHD patients (compared with male healthy controls) was more
everely impaired than in female ADHD patients (compared with
emale healthy controls) (Lipszyc and Schachar, 2010).
Consistent evidence for sex differences in brain struc-
ure/function within ADHD cohorts has been limited (Castellanos
t al., 2001; Hill et al., 2003), in agreement with the idea of
elatively subtle differences in symptomatology and neuropsycho-
ogical function between ADHD males and females. However, it
s also possible that true sex differences in these domains may
e obscured by confounds including the age of the patients being
canned, the small study sizes, their different treatment regimes
nd of the variability inherent in diagnosis of the disorder. Indeed,
 recent study by Valera et al. (2010) in which some of these con-
ounds were addressed has revealed that whilst adult ADHD males
nd females did not differ in their behavioural performance on
 working memory task, male ADHD cohorts exhibited reduced
ctivity in a number of pertinent brain structures (frontal, tem-
oral and cerebellar regions) relative to control males; in contrast,
emales with ADHD did not show a similar attenuation in activity
elative to female controls. First-line treatments for ADHD, such as
he psychostimulant methylphenidate, are thought to exert their
rimary effects through enhancing dopaminergic neurotransmis-
ion (thereby counteracting dysregulated dopamine pathways in
DHD) (Heal et al., 2009) and, although they may  be metabolised
ifferently in males and females, appear to be equally efﬁcacious in
oth sexes (Cornforth et al., 2010; Gunther et al., 2010; Rucklidge,
010). However, a recent study has uncovered between-sex dif-
erences in the efﬁcacy of a newer ADHD treatment, atomoxetine
which acts primarily as a noradrenaline re-uptake inhibitor), with
etter outcomes in females compared with males (Marchant et al.,
011).
.2. Other neuropsychiatric disorders
Autism spectrum disorders (ASDs) are characterised by abnor-
alities in social function and communication, excessive anxiety
nd high levels of repetitiveness (American Psychiatric Association,
994; Lord et al., 2001). As with ADHD, family, twin and adoption
tudies have indicated that vulnerability to ASDs is inﬂuenced to
 large extent by genetic factors (Abrahams and Geschwind, 2008;
ailey et al., 1995; Folstein and Rutter, 1977). Although ASDs are
ot generally considered disorders of inattention or impulsivity
er se, it is estimated that 30–80% of ASD children meet symp-
om criteria for ADHD (Carpenter Rich et al., 2009; Hattori et al.,
006; Lee and Ousley, 2006; Simonoff et al., 2008). ASDs dispro-
ortionately affect males (male:female prevalence ratio is ∼4:1)
Fombonne, 2002) and it has been proposed that autistic behaviours
nd neurobiology represent extremes of those which distinguish
ales from females (the ‘Extreme Male Brain Theory’; Baron-
ohen, 2002; Baron-Cohen et al., 2005). Whilst studies explicitly
omparing attention and impulse control in male and female ASD
ubjects are rare, there is some evidence that female patients may
xhibit more inattentive symptoms (Holtmann et al., 2007) and
oorer response inhibition as indexed by SSRT task performance
Lemon et al., 2011) than their male counterparts. The neurobio-
ogical substrates underlying these behavioural differences in this
linical group remain to be elucidated; candidate brain regions may
nclude the temporal lobe and cerebellar grey matter (both reduced
n size in female ASD subjects) (Bloss and Courchesne, 2007).Addictive behaviours, such as gambling and drug abuse, can
e conceptualised as impulsive choices, whereby smaller, imme-
iate rewards are favoured over larger, delayed rewards (Petry and
asarella, 1999). Pathological gambling, the maladaptive behaviourychology 89 (2012) 1– 13
of gambling in spite of adverse consequences (Alessi and Petry,
2003), is characterised by high levels of impulsivity (American
Psychiatric Association, 1994; Blaszczynski et al., 1997; Petry, 2001;
Steel and Blaszczynski, 1998) and frequently co-occurs with ADHD
(Derevensky et al., 2007; Specker et al., 1995). Furthermore, gen-
der differences in gambling have been described in aspects of
incidence (males are at an increased risk), age of onset (earlier
age of onset in males), course (females have quicker progression
to pathological gambling), gambling preferences and comorbid-
ity with alcohol abuse (more common in men) (Johansson et al.,
2009; Martins et al., 2008; Tavares et al., 2001). Despite a grow-
ing trend towards research into female gamblers (Martins et al.,
2002), we  are unaware of any study speciﬁcally examining sex dif-
ferences in impulsivity levels amongst pathological gamblers. Drug
abuse is the acquisition and initiation of substances such as opiates,
nicotine, alcohol, cocaine and psychomotor stimulants, all of which
may  lead to addiction (Le Moal and Koob, 2007). Similar to patho-
logical gambling, drug abuse is closely associated with impulsive
behaviour (Perry and Carroll, 2008), such that drug abusers are sig-
niﬁcantly more impulsive than controls (Kirby et al., 1999; Madden
et al., 1997; Vuchinich and Simpson, 1998). In fact, the association
between impulsivity and drug abuse may  explain the high comor-
bidity between drug abuse and ADHD (Schubiner, 2005), especially
given that the inattentive ADHD subtype was  found to be less of
a risk for substance abuse than the hyperactive-impulsive subtype
(Elkins et al., 2007). Sex differences have been reported in all facets
of human and animal drug abuse including initiation, escalation,
addiction and relapse following withdrawal (Becker and Hu, 2008;
Carroll et al., 2004; Lynch et al., 2002; Roth et al., 2004). For example,
the rate of escalation of drug use and risk of relapse following absti-
nence is greater in females compared to males (Brady and Randall,
1999; Breese et al., 2005; Carpenter et al., 2006; Hernandez-Avila
et al., 2004; Mann et al., 2005). Meanwhile, sex differences in impul-
sivity have been reported in human drug abusers (Lejuez et al.,
2007) and rat models of drug abuse (Anker et al., 2008; Perry
et al., 2007), with greater impulsivity found amongst drug abusing
females compared with corresponding drug abusing males.
5. Genetic mechanisms of sexual differentiation of the
brain
Ultimately, sex differences in behaviour and cognition must
stem from the fact that the two sexes inherit different chromosomal
complements: males inherit one cognition-gene rich X chromo-
some (invariably from their mother) (Zechner et al., 2001), and
a Y chromosome from their father, whereas females inherit two
X chromosomes, one from either parent. Accumulating data from
the elegant mouse models has shown that in mammals, genes on
the sex chromosomes (the X and Y) may  inﬂuence neurobiology
directly (through inﬂuencing neurodevelopment and/or ongoing
brain function), or may  inﬂuence neurobiology indirectly through
affecting some intermediary pathway (notably gonadal hormone
secretion and function) (Arnold and Chen, 2009; Dewing et al.,
2003, 2006). There is evidence for multiple gene expression dif-
ferences between regions of male and female brains relevant to
attention and impulsivity i.e. the dorsolateral prefrontal cortex, the
anterior cingulate cortex and the cerebellum (Vawter et al., 2004);
it is likely that these expression differences are the upshot of a
complex interaction between sex chromosome complement and
hormonal milieu.
Multiple lines of evidence have suggested a strong genetic com-
ponent to attention and impulsivity phenotypes, including data
from family, twin and adoption studies for disorders of atten-
tion/impulsivity such as ADHD (Faraone et al., 2005; Sharp et al.,
2009; Thapar et al., 2007), and the fact that rats can be selectively
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red so as to exhibit inattentive and impulsive phenotypes (Moreno
t al., 2010; Sagvolden et al., 2005). In the case of twin studies, both
ualitative and quantitative genetic sex differences (measured as
ifferences in correlations between opposite sex dizygotic twins
ith same-sex dizygotic twins and between male monozygotic
wins with female monozygotic twins, respectively) have been
eported in the hyperactivity levels of 7-year olds (Saudino et al.,
005). However, this was only evident in same-teacher scores and
ot parent scores, whilst two other twin studies that speciﬁcally
ssessed ADHD symptoms, demonstrated a lack of quantitative and
ualitative genetic sex differences using the Revised Connor’s Par-
nt Rating Scale (Greven et al., 2011; Kuntsi et al., 2005) and a
eta-analysis of twin studies did not reveal an effect of sex on
DHD symptom dimensions (Nikolas and Burt, 2010).
Evidence for the involvement of sex-linked genes speciﬁcally
n mediating altered attention/impulsivity phenotypes has come
rom a combination of comparing males and females on measures
f attention/impulsivity (described above), studying cohorts with
nusual sex chromosome constitutions, from studying individu-
ls with discrete mutations on the X or Y chromosomes, from
inkage/association studies and from work in animal models. For
xample, using an elegant animal model, the so-called ‘four-core
enotypes’ cross in which the direct effects of sex-linked genes on
eurobiology may  be dissociated from their downstream effects
n gonadal hormone-mediated effects on neurobiology (De Vries
t al., 2002), it has been shown that chromosomally female mice
XX) showed faster food-reinforced instrumental habit formation
han chromosomally male mice (XY), irrespective of their gonadal
ype (Quinn et al., 2007). This ﬁnding suggests that the greater
scalation of drug use in females, and more rapid progress to addic-
ion in this sex, may  be dependent upon the actions of sex-linked
enes.
There are three general mechanisms through which genes on
he sex chromosomes may  inﬂuence sex-speciﬁc neurobiology
Davies et al., 2005). First, genes on the Y chromosome can only
e expressed in male brain cells (Kopsida et al., 2009). Second,
-linked genes that escape the process of X-inactivation (Ohno
t al., 1959; Reik and Lewis, 2005) (∼20% of all X-linked genes
n man) will be expressed more highly in female than male brain
s a consequence of the fact that females possess two copies of
ny given X-linked gene, whereas males only possess one; more-
ver, male hemizygosity for X-linked genes (i.e. the fact that males
nly possess one allele of each such gene), means that these
lleles will be able to directly inﬂuence phenotype. In females,
he effect of any particular X-linked allele on phenotype may  be
asked by the effect of the allele on the opposite X chromo-
ome. Finally, so-called ‘imprinted’ genes on the X chromosome
ay, in theory, be differentially expressed in male and female
rain (Davies and Wilkinson, 2006): genes expressed solely from
he paternally inherited X chromosome can only be expressed in
emale brain (as only females inherit an X chromosome from their
ather), whereas genes expressed from the maternally inherited X
hromosome may  be expressed in both sexes, but may  be more
ighly expressed in male brain if they are subject to X-inactivation.
hilst there are many examples of Y-linked genes and X-linked
osage-sensitive genes that inﬂuence physiology in man, currently
he effect of X-linked imprinted genes on brain and behaviour in
an  remains theoretical given that no such genes have yet been
dentiﬁed. In addition to these mechanisms, it is possible that regu-
atory elements on the sex chromosomes may  inﬂuence autosomal
ene expression and that chromosomal interactions within the
ucleus involving the X and Y chromosomes may  inﬂuence sex-
peciﬁc gene expression (Eskiw et al., 2010; Heard and Bickmore,
007).
Perturbations to these genetic mechanisms of sexual differenti-
tion of the brain (via chromosomal abnormalities for example)ychology 89 (2012) 1– 13 5
may  result in abnormal attentional and/or impulsivity pheno-
types. Subjects with such chromosomal abnormalities are relatively
rare and their phenotype varies considerably, and as such, data
from such studies should be treated with a degree of caution.
Males with multiple Y chromosomes, and therefore over-dosage
of Y-linked genes (most commonly karyotype 47,XYY), have been
reported to exhibit relatively high rates of attentional deﬁcits
(distractibility) and ADHD (Linden and Bender, 2002; Ross et al.,
2009; Ruud et al., 2005). These ﬁndings are somewhat consis-
tent with evidence for impaired response inhibition in 47,XYY
males (Ross et al., 2009). A report of a male with a major de
novo mutation of the Y chromosome (deletion of the long arm,
together with duplication of the short arm) and ADHD suggests
the possibility that over-dosage of Y-linked genes on the short
arm and/or absence of Y-linked genes on the long arm could
be important in mediating ADHD vulnerability (Mulligan et al.,
2008).
Evidence for X-linked gene dosage being important in mediat-
ing attentional/impulsive function has come from studying subjects
with Turner syndrome (TS; the majority of whom possess a single X
chromosome only, karyotype 45,X) and Klinefelter syndrome (KS;
males possessing an additional X chromosome of either paternal or
maternal origin, karyotype 47,XXY). Both of these disorders present
with endocrinological abnormalities (Gravholt, 2004; Lanfranco
et al., 2004), so any behavioural deﬁcits associated with these
conditions could be a direct consequence of altered gene dosage
within the brain, or to brain effects mediated indirectly by sys-
temic gonadal hormone levels. Rates of ADHD, and particularly
the hyperactive-impulsive subtype, are signiﬁcantly higher in TS
individuals than in control 46,XX subjects (Russell et al., 2006), pre-
sumably as a consequence of haploinsufﬁciency (reduced dosage)
for one or more X-linked genes that typically escape X-inactivation;
TS subjects also show impairments across a number of neuropsy-
chological tests taxing attention and/or impulsivity (Nijhuis-van
der Sanden et al., 2003; Ross et al., 2002; Rovet and Ireland, 1994).
Interestingly, 39,XO mice, a putative model for aspects of TS neu-
robiology (Lynn and Davies, 2007), show deﬁcits in visuospatial
attention which recapitulate those seen in TS subjects (Davies
et al., 2007) implicating the few X-linked genes that escape X-
inactivation in both mouse and man  as candidates underlying this
behavioural abnormality. The evidence for attentional/impulsivity
impairments in KS subjects is less strong than that for TS; however,
again this group may be at a slightly elevated risk of developing
ADHD, be more distractible, and show deﬁcits in some forms of
executive function (Leggett et al., 2010; Linden and Bender, 2002;
Ross et al., 2009). The combined TS and KS data suggest the possi-
bility that altered X-linked gene dosage in either direction (either
under, or over-dosage) may  result in phenotypically similar out-
comes.
6. Candidate sex-linked genes inﬂuencing attention and
impulsivity
The sex-linked genes SRY, STS and MAOA represent clear
positional and/or functional candidates for effects on atten-
tional and impulsive behaviours. For instance, SRY, either directly
via neural expression or indirectly through downstream effects
on gonadal hormone levels, may  mediate dopaminergic effects
linked with attention and impulsivity (Boulougouris and Tsaltas,
2008; Dewing et al., 2006). MAOA may  similarly inﬂuence gen-
eral monoaminergic function (Shih et al., 1999), whereas STS
has been implicated in both neuropsychological domains (Kent
et al., 2008; Stergiakouli et al., 2011). Below we discuss the
three candidate sex-linked genes in further detail (also shown in
Fig. 1).
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Fig. 1. The genetic mechanisms that underlie attention and impulsivity in both the healthy and the neuropsychiatric population. The expression of sex linked genes including
SRY,  STS and MAOA are sexually dimorphic (SRY is only expressed in males and STS has a higher expression in females). As a consequence, sex differences may occur in their
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.1. SRY
One obvious candidate sex-linked gene is the sex-determining
ene itself, SRY (Sex-determining Region on the Y) (Sekido and
ovell-Badge, 2009). SRY gene is a Y-linked gene (Yp11.3) (and
ence male-speciﬁc) which encodes a protein with a DNA-binding
otif. This protein acts as a transcription factor in the bipotential
onad of the developing fetus to induce gene expression changes
hich facilitate differentiation into testicular tissues (Berta et al.,
990; Kashimada and Koopman, 2010; Sinclair et al., 1990). Once
ormed, the Leydig cells of the testis secrete testosterone in the
resence of luteinising hormone; this testosterone (and its metabo-
ites) may  then masculinise the brain through acting at androgen
r oestrogen receptors (Zuloaga et al., 2008). Besides acting as a SRY). In turn, sexually dimorphic neurobiological alterations in cognitive-associated
ﬁc nuances in attention and impulsive behaviour amongst the healthy population,
key molecular switch in the gonads, recent data has shown that
SRY may  also act as a transcriptional regulator in the brain. In
rodents, the gene is highly expressed in the substantia nigra (SN)
and ventral tegmental area (VTA) brain regions (Dewing et al., 2006;
Lahr et al., 1995); these areas are highly enriched for dopaminergic
neurons, which project to the frontal cortex and striatum (Thierry
et al., 2000). In man, SRY has been reported as being expressed
in adult frontal and temporal cortex, and in the medial rostral
hypothalamus (Mayer et al., 1998); it is likely that, as in rodents,
SRY is also expressed in the SN/VTA of human males, but this has
yet to be investigated. The pattern of SRY expression prompted
researchers to investigate whether its associated protein could
act as a transcription factor for important genes in monoamine
metabolism. Promoter-binding and immunoprecipitation assays
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ave since demonstrated that SRY may  act as a transcriptional
ctivator for TH (the gene encoding the rate-limiting enzyme in
opamine biosynthesis tyrosine hydroxylase) (Milsted et al., 2004)
nd for MAOA (the X-linked gene encoding the enzyme monoamine
xidase involved in monoamine breakdown) (Wu et al., 2009); the
act that knockdown of SRY expression in the rat SN results in
educed TH protein provides evidence that these ﬁndings may  have
elevance in vivo (Dewing et al., 2006).
Hence, SRY represents an excellent candidate for sex-speciﬁc
ffects on cognitive domains that are known to be highly sensi-
ive to dopaminergic function in the frontal cortex and striatum,
ncluding attention/impulsivity (Boulougouris and Tsaltas, 2008;
ieoullon, 2002; Pattij and Vanderschuren, 2008; Robbins and
oberts, 2007; Winstanley et al., 2006), in the normal and patho-
ogical ranges. Both ADHD and addictive behaviours are highly
ale-biased in their prevalence, and are associated with dopamin-
rgic dysregulation (Andersen and Teicher, 2000; Hyman et al.,
006; Quinn et al., 2007). SRY could potentially also act as an
ndirect mediator of attention/impulsivity via its downstream
ffects on testosterone secretion. Testosterone levels may  inﬂuence
ttention/impulsivity in individuals with attentional/impulsive
ysfunction (Baron-Cohen et al., 2005; de Bruin et al., 2006; Martel
t al., 2009), although it is less clear whether this is mirrored in
ealthy individuals (Bjork et al., 2001; Cherrier et al., 2002; Wolf
nd Kirschbaum, 2002). SRY overexpression represents a plausi-
le candidate genetic mechanism underlying the increased risk of
ttentional problems in subjects with duplication of the short arm
f the Y chromosome (Mulligan et al., 2008) and 47,XYY individuals.
f SRY does mediate attention/impulsivity phenotypes, we  might
urther speculate that females with Swyer syndrome who possess
 46,XY chromosomal constitution but who commonly lack a func-
ional SRY gene, might display abnormalities in these domains.
Just as Y-linked genes such as SRY may  inﬂuence sex-speciﬁc
ognitive attributes, so too might X-linked genes, whether that
e through the effects of increased dosage of genes escaping X-
nactivation in females, or through expression of particular alleles
n hemizygous males but not in homo- or heterozygous females.
.2. STS
The most parsimonious explanation for the attentional
mpairments in individuals with TS, and in 39,XO mice, is haploin-
ufﬁciency for one or more X-linked genes that typically escape
-inactivation in both species. The fact that the 39,XO mouse deﬁcit
ould be rescued in 40,XY*X mice (essentially 39,XO mice with a few
dditional X-linked genes on the small Y*X chromosome) suggested
hat one of the genes on this chromosome could inﬂuence attention.
he most promising candidate gene on the basis of its function, and
he fact that it was already known to escape X-inactivation, was
TS, encoding the enzyme steroid sulfatase (Davies et al., 2007).
teroid sulfatase catalyses the desulfation of the various neuros-
eroids thus modulating their activity, e.g. dehydroepiandrosterone
ulfate (DHEAS) to DHEA (Reed et al., 2005). Neurosteroids are syn-
hesised in the brain, as opposed to the adrenal glands and gonads
Dubrovsky, 2005), and have numerous neural functions includ-
ng effects on neuronal excitability (DHEAS is a potent negative
llosteric modulator of GABA receptors) and gene transcription via
uclear steroid receptors (Belelli and Lambert, 2005; Rupprecht and
olsboer, 1999). In man, the STS gene is X-linked (Xp22.3), escapes
-inactivation (Shapiro et al., 1979) and has a non-expressed Y-
inked homologue (Yen et al., 1988). A priori, one may  expect
xpression to be higher in female than male tissues. Whilst there
s indeed some evidence for greater activity in accessible tissues
n human females (Cuevas-Covarrubias et al., 1993), and in female
rain tissue from monkeys (Kriz et al., 2005) as yet there is no robust
ata on the expression/activity of the enzyme in regions of male andychology 89 (2012) 1– 13 7
female human brain relevant to attentional and impulsive pheno-
types. Hence, whilst STS could theoretically underlie sex differences
in these domains, this idea remains to be formally tested.
There are multiple strands of evidence suggesting a role for
steroid sulfatase in attentional and impulsivity phenotypes. First,
it has recently been shown that STS is expressed in regions of
the developing brain key to attentional and impulsive operations
including the cerebral cortex, the thalamus and the basal gan-
glia i.e. regions whose structure/function is perturbed in ADHD
(Stergiakouli et al., 2011). Second, males with deletions of the
gene (or inactivating mutations within the gene) are at signiﬁ-
cantly increased risk of developing ADHD (notably the inattentive
subtype) relative to the general population (Kent et al., 2008).
Third, speciﬁc single nucleotide polymorphisms within the gene
may be associated with an increased risk of developing ADHD, and
an increased number of inattentive symptoms in ADHD cohorts
(Brookes et al., 2008, 2010; Stergiakouli et al., 2011). Fourth,
DHEA(S) levels are inversely correlated with ADHD symptomatol-
ogy (Strous et al., 2001) and may  be elevated by methylphenidate
treatment (Maayan et al., 2003). Finally, mice with deletions
encompassing the STS gene (or mice in which the enzyme’s activity
has been inhibited) show visuospatial attentional deﬁcits, reduced
levels of impulsive action (as indexed by performance on mouse
variants of the 5-CSRT and SSRT tasks), elevated levels of aggres-
sion and increased locomotor activity (Davies et al., 2009; Nicolas
et al., 2001; Trent et al., 2011; Humby et al., manuscript in prepara-
tion). Given this mounting experimental support, STS represents a
strong candidate gene for neurocognitive deﬁcits in TS, which have
previously been mapped to Xp22.3 (Zinn et al., 2007).
To date, there is limited data on the neurobiological processes
through which altered STS expression/function might mediate
effects on attention and impulsivity. At the neurotransmitter level,
rodent work has shown that steroid sulfatase inhibition may
elicit elevated hippocampal acetylcholine release (Rhodes et al.,
1997). Together with data showing that enzyme inhibition affects
response accuracy in the visuospatial 5-CSRT task, we may spec-
ulate that steroid sulfatase activity is particularly important in
orienting. Neurosteroids whose activity may  be modulated by
the steroid sulfatase enzyme could potentially modulate GABAer-
gic and glutamatergic (NMDA) function (Dubrovsky, 2005; Zheng,
2009). Future work in model systems and humans should aim
to examine how steroid sulfatase manipulations inﬂuence neu-
rodevelopment, neurotransmitter balance and speciﬁc aspects of
attention/impulsive behaviour.
6.3. MAOA
The X-linked MAOA gene (Xp11.3) encodes the mitochondrial
enzyme monoamine oxidase A (MAOA) (Bach et al., 1988; Lan
et al., 1989); this enzyme plays a vital role in the metabolism
of monoamine neurotransmitters, catalysing the oxidisation of
serotonin, noradrenaline and dopamine (Bortolato et al., 2008;
Shih et al., 1999). The ability of monoamine oxidase to regulate
monoaminergic systems makes it a prime candidate for effects
on cognition and for vulnerability to disorders of attention and
impulsivity such as ADHD. There is the possibility that MAOA
expression/function is regulated in a sex-speciﬁc manner in one of
two ways: (i) it may  be a downstream effector for SRY in the brain,
as described previously or (ii) it may  partially escape X-inactivation
in some tissues in humans; however, the data for this from studies
using ﬁbroblasts and hybrid cell work are inconclusive (Carrell and
Willbard, 2005; Stabellini et al., 2009), and no comprehensive stud-
ies assaying escape from X-inactivation have yet been performed
using discrete regions of the human brain.
As with steroid sulfatase, the evidence linking monoamine
oxidase function with attentional, and particularly impulsive,
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henotypes has come from a variety of sources: (i) inactivating
utations within the gene may  lead to extreme impulsiveness
nd aggression in males (Brunner et al., 1993), whilst knockout
f the MAOA gene in mice results in enhanced aggression (Cases
t al., 1995), (ii) certain MAOA alleles may  be associated with
ttention, impulsivity and aggression in healthy individuals, and
ay  inﬂuence function of the anterior cingulate cortex (Fan et al.,
003b; Fossella et al., 2002; Manuck et al., 2000), (iii) associa-
ion between MAOA polymorphisms (including the 30 base pair
ariable number tandem repeat sequence near the promoter) and
ulnerability to ADHD (Gizer et al., 2009); these associations are
ypically heterogeneous across studies, and may  be inﬂuenced
y pervasive genotype–environment interactions (Kinnally et al.,
009) and (iv) the ﬁnding that methylphenidate, the predomi-
ant treatment for ADHD, inhibits monoamine oxidase activity
Solanto, 1998). There is some genetic evidence that the X-linked
ene MAOB (Xp11.23) encoding the enzyme monoamine oxidase
 (which is more selective than monoamine oxidase A and prefer-
ntially modulates degradation of dopamine), may  also inﬂuence
ttention/impulsivity phenotypes and vulnerability to ADHD (Li
t al., 2008), although the evidence that this gene may  inﬂuence
mpulsivity is less strong than for MAOA.  However, low levels of
onoamine oxidase B activity in platelets have been associated
ith increased sensation seeking behaviours and impulsiveness
Oreland et al., 2002).
. Sex-linked effects on autosomal genes
This review has focussed on sex-linked genetic mechanisms that
ay underlie attentional and impulsive phenotypes in mammals.
owever, there are without doubt a large number of autosomal
enes whose products are likely to affect the phenotypes of interest
ere. It is possible that the expression/function of such autosomal
enes may  be modulated by sex, either by the products of sex-
inked genes directly (e.g. SRY acting as a transcriptional activator
or the autosomal TH gene), or by the downstream pathways inﬂu-
nced by sex-linked genes such as gonadal hormone systems. One
nteresting gene in this regard is COMT (22q11.21) which encodes
he enzyme catechol-O-methyltransferase. COMT was  implicated
s a candidate gene for ADHD based on its high frontal cortex
xpression, its absence in ADHD-prone 22q11 deletion syndrome
atients, and its role in catecholamine metabolism (Gizer et al.,
009). Most studies to date have failed to identify a signiﬁcant
ssociation between COMT polymorphisms and ADHD; two stud-
es have suggested that sex may  moderate an association between
he most intensively studied Val/Met polymorphism and ADHD,
hereby possessing the methionine (Met) allele conferred risk
f ADHD in boys, whereas possessing the valine (Val) allele con-
erred risk of developing ADHD in girls (Biederman et al., 2008;
ian et al., 2003). In further support, sex differences are often
bserved in the correlations between substance use, a neuropsy-
hiatric disorder characterised by high levels of impulsivity, and the
OMT Val108/158Met polymorphism (Tammimaki and Mannisto,
010). The idea of an allele by gender interaction is consistent with
bservations that catechol-O-methyltransferase activity is greater
n male prefrontal cortex (Chen et al., 2004) and that COMT homozy-
ous knockout male mice have a twofold increase in dopamine
evels in the prefrontal cortex compared with male wildtypes,
hereas no such discrepancy occurs between female knockout
ice and their wildtype counterparts (Gogos et al., 1998).. Summary and future work
There is persuasive evidence that the sexes differ with respect to
heir relative vulnerability to disorders of attention and impulsivity.ychology 89 (2012) 1– 13
Moreover, there is putative evidence that healthy males and
females show differences in their attentional and impulsive pro-
ﬁles, and in the brain structures underlying these cognitive
processes. However, these latter ﬁndings are, at present, inconsis-
tent and the ﬁeld requires further exploration. These sex differences
in neurobiology must be underpinned by genes on the X and Y
chromosomes exerting their effects by either direct action in the
brain or via intermediary mechanisms such as systemic hormone
secretion; here, we have reviewed several plausible mechanisms
via which genes on the sex chromosomes may  inﬂuence attention
and impulsivity.
Future work, utilising state-of-the-art imaging techniques,
should try to specify more accurately the neuropsychological and
neuroanatomical differences that distinguish healthy males and
females, male/female controls from their counterparts presenting
with disorders of attention or impulsivity, controls from subjects
with sex chromosome anomalies, and controls from subjects with
mutations within speciﬁc sex-linked genes. To achieve the ﬁrst two
objectives, sex difference studies should ideally be planned a pri-
ori rather than analysing data from males and females a posteriori.
Additional useful work in humans might focus upon identify-
ing potential regions of interest underlying attention/impulsivity
phenotypes on the X chromosome using large scale linkage or
association or copy number variant analyses, although the idiosyn-
cratic nature of this chromosome makes it difﬁcult to study using
standard methods (Ross et al., 2006; Schaffner, 2004). Finally,
animal work may  enable us to dissociate between sex-linked
genes inﬂuencing attention/impulsivity directly, or via gonadal
hormonal mechanisms (Arnold and Chen, 2009) and to examine the
neurobiological systems underlying altered attention/impulsivity
more intimately. Ultimately, identifying protective or risk factors
encoded by sex-linked genes should enable us to develop more
effective methods of treating sex-biased disorders of attention and
impulsivity.
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